Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Nevro Corp    NVRO

NEVRO CORP (NVRO)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/11/2018 07/12/2018 07/13/2018 07/16/2018 07/17/2018 Date
67.2(c) 68.04(c) 57.77(c) 58.71(c) 58.99 Last
2 046 382 825 782 6 486 508 2 162 163 328 081 Volume
+4.93% +1.25% -15.09% +1.63% +0.48% Change
More quotes
Financials (USD)
Sales 2018 392 M
EBIT 2018 -24,5 M
Net income 2018 -35,6 M
Finance 2018 45,0 M
Yield 2018 -
Sales 2019 457 M
EBIT 2019 1,70 M
Net income 2019 -7,44 M
Finance 2019 96,8 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 4,30x
EV / Sales2019 3,58x
Capitalization 1 732 M
More Financials
Company
Nevro Corp. engages in the provision of medical devices.It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain.The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood... 
More about the company
Surperformance© ratings of Nevro Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on NEVRO CORP
07/16NEVRO CORP : Results of Operations and Financial Condition, Financial Statements..
AQ
07/16NEVRO : Announces Preliminary Unaudited Second Quarter 2018 Revenue and Updates ..
PR
07/16Free Pre-Market Technical Recap on Nevro and Three Additional Medical Equipme..
AC
07/13NEVRO : to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Y..
PR
07/13NEVRO CORP : Change in Directors or Principal Officers (form 8-K)
AQ
05/25NEVRO CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/17NEVRO : Spinal Cord Stimulator Implants
AQ
05/14NEVRO : Recognized as a "Best Place to Work" in the Bay Area
PR
05/10New Spinal Cord Findings from S.M Falowski and Co-Researchers Described (An O..
AQ
05/09NEVRO : Reports First Quarter 2018 Financial Results
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/11MEDTRONIC : Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure
DJ
07/09BECTON DICKINSON AND : Completes Acquisition of TVA Medical
DJ
06/29ESSILOR INTERNATIONAL : Luxottica, Essilor extend deadline for merger pending Ch..
RE
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10:04aNevro $NVRO Downgraded by ValuEngine  
07/16Co’s that have issued in the last 30 days $NVRO $GOGO $INGR $SAL $VMI $BABY.. 
07/16JOIN THE SUMMER TEST DRIVE! You are invited to test drive TI prem..
3
07/16$NVRO: Nevro sees Q2 revs slightly above consensus; lowers FY18 rev guidance ..
1
07/16Nevro announces preliminary Q2 and FY18 revenue  
More tweets
Qtime:32
News from SeekingAlpha
07/16Nevro announces preliminary Q2 and FY18 revenue 
07/13Nevro up 1% after hours ahead of business update and Q2 results 
07/13Midday Gainers / Losers (07/13/2018) 
07/13HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (7/13/2018) 
07/13Nevro axes sales chief; shares down 15% 
Chart NEVRO CORP
Duration : Period :
Nevro Corp Technical Analysis Chart | NVRO | US64157F1030 | 4-Traders
Technical analysis trends NEVRO CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 84,8 $
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Rami Elghandour President, Chief Executive Officer & Director
Michael F. DeMane Chairman
Patrick Schmitz Vice President-Operations
Andrew H. Galligan Chief Financial Officer
Bradford E. Gliner Vice President-Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
NEVRO CORP-14.96%1 732
MEDTRONIC PLC9.42%119 437
BAXTER INTERNATIONAL14.50%40 217
ALIGN TECHNOLOGY63.05%29 130
ZIMMER BIOMET HOLDINGS-6.66%23 354
HOYA CORPORATION10.59%21 537